Skip to main content
OpenTrials

Clinical trial condition

Acute Adult T-Cell Leukemia/Lymphoma

Explore clinical trials studying Acute Adult T-Cell Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Acute Adult T-Cell Leukemia/Lymphoma trial results

Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

NCT04301076

Conditions
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +21 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
  • Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
View all 19 locations
View Trial Details
Completed

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

NCT02631746

Conditions
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +23 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details

Related conditions